查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1862208

器官晶片（OoC）：全球市场份额和排名、总收入和需求预测（2025-2031 年）

Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 152 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球器官晶片(OoC) 市场规模估计为 1.66 亿美元，预计到 2031 年将达到 10.76 亿美元，2025 年至 2031 年的复合年增长率为 30.2%。

器官晶片（OoC）模型是一种微型装置，能够模拟人体器官的机械和生物特性。这些晶片包含衬有活体人体细胞的微通道，形成组织层。它们可以模拟各种器官的生理功能，包括心臟、肝臟、肺臟、肾臟和肠道，使研究人员更深入地了解器官特异性功能和疾病。这些模型通常采用微流体技术製造。在微型透明晶片内培养人体细胞，使研究人员能够模拟器官特异性功能，并研究疾病进程、药物反应等。透过提供更准确、扩充性且与人体相关的数据，人体器官晶片正在革新生物医学研究和药物测试，以弥合传统动物模型和人体临床试验之间的鸿沟。

器官晶片（OoC）市场的主要驱动力是人们对高效、精准且符合伦理规范的体外生物模型日益增长的需求。传统的药物研发方法成本高、耗时费力，且临床成功率低。相较之下，器官器官晶片（OoC）技术能够忠实地模拟人体器官的微环境和功能，为提高药物筛检的效率和预测准确性提供了一种极具前景的替代方案。此外，北美和欧洲等地区对动物实验的监管日益严格，也加速了符合「3R」原则（替代、减少和优化）的先进替代方法的普及，使得器官晶片（OoC）成为一种符合伦理的理想解决方案。同时，个人化和精准医疗的兴起也推动了利用患者来源细胞进行个人化药物测试和疗效预测的器官晶片技术的应用。再生医学、免疫疗法和生物工程领域的技术进步正在推动器官晶片系统的多样化和平台化。此外，公共和私营部门对生物技术领域的持续投资也促进了器官晶片平台的商业化。随着多器官晶片的不断发展，并与人工智慧、生物感测器和其他数位健康技术融合，预计在药物研发、毒性测试和疾病建模等高价值应用领域，市场将迎来快速成长。

全球主要的器官晶片（OoC）生产商包括Emulate、Mimetas和Tissuse。这三大公司占了约40%的市占率。在全球范围内，器官晶片（OoC）主要产自美国和欧洲，这两个地区的市占率均超过80%。北美是最大的市场，约占43%的市场份额，其次是欧洲（37%）和日本（8%）。

本报告旨在按地区/国家、类型和最终用户对全球 OoC（器官晶片）市场进行全面分析，重点关注总收入、市场份额和主要企业的排名。

本报告基于2020年至2031年的历史数据和预测数据（以2024年为基准年），对器官晶片（OoC）市场的收入（百万美元）进行了估算和预测。报告的定量和定性分析旨在帮助读者制定业务和成长策略，评估竞争格局，分析自身在当前市场中的地位，并就器官晶片（OoC）做出明智的商业决策。

市场区隔

公司

  • Emulate
  • Mimetas
  • TissUse
  • Valo Health
  • CN Bio Innovations
  • Hesperos
  • Draper Laboratory
  • Nortis
  • Micronit Microtechnologies BV
  • Kirkstall
  • Cherry Biotech SAS
  • Else Kooi Laboratory
  • Altis Biosystems
  • Bi/ond
  • Netri
  • Xona Microfluidics
  • SynVivo, Inc.
  • Beijing Daxiang Biotech
  • AVATARGET
  • Suzhou Jiyan Biopharmaceutical
  • InSphero

按类型分類的细分市场

  • Brain-on-a-chip
  • Liver-on-a-chip
  • Kidney-on-a-chip
  • Lung-on-a-chip
  • Heart-on-a-chip
  • Intestine-on-a-chip
  • Vessel-on-a-chip
  • 其他组织

最终使用者群体

  • 製药和生物技术公司
  • 学术和研究机构
  • 化妆品产业
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Organ On Chip was estimated to be worth US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.

A Organ on Chip is a small-scale device that replicates the mechanical and biological properties of human organs. These chips contain tiny channels lined with living human cells that form tissue layers. They can simulate the physiology of various organs, such as the heart, liver, lungs, kidneys, and intestines, allowing researchers to better understand organ-specific functions and diseases. These models are typically made using microfluidic technology, where human cells are cultured in a small, transparent chip, allowing researchers to simulate organ-specific functions and study disease processes, drug responses, and more. By offering more accurate, scalable, and human-relevant data, Human Organs-on-Chips are revolutionizing biomedical research and drug testing, providing a bridge between traditional animal models and human clinical trials.

The organ-on-a-chip market is primarily driven by the growing demand for more efficient, accurate, and ethically compliant in vitro biological models. Traditional drug development methods are often costly, time-consuming, and have low clinical translation success rates. In contrast, organ-on-a-chip technology, which closely mimics the microenvironment and functions of human organs, offers a promising alternative to improve drug screening efficiency and predictive accuracy. Increasing restrictions on animal testing, especially in regions like North America and Europe, are also accelerating the adoption of advanced alternatives that align with the "3Rs" principle-Replacement, Reduction, and Refinement-making organ-on-a-chip an ethically favorable solution. Furthermore, the rise of personalized and precision medicine is driving the use of patient-derived cells in organ chips for individualized drug testing and response prediction. Technological advancements across regenerative medicine, immunotherapy, and bioengineering are supporting the diversification and platformization of organ chip systems. In addition, sustained investment from both the public and private sectors in biotechnology is facilitating the commercialization of organ-on-a-chip platforms. As multi-organ chips evolve and integrate with AI, biosensors, and other digital health technologies, the market is expected to see rapid growth across high-value applications such as drug discovery, toxicity testing, and disease modeling.

Global main manufacturers of organ-on-chip include Emulate, Mimetas and TissUse, etc. The top three players hold a share about 40%. The global organ-on-chip is mainly produced in United States and Europe, they occupied for a share over 80%. North America is the largest market, has a share about 43%, followed by Europe and Japan, with share 37% and 8%, separately.

This report aims to provide a comprehensive presentation of the global market for Organ On Chip, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Organ On Chip by region & country, by Type, and by End User.

The Organ On Chip market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organ On Chip.

Market Segmentation

By Company

  • Emulate
  • Mimetas
  • TissUse
  • Valo Health
  • CN Bio Innovations
  • Hesperos
  • Draper Laboratory
  • Nortis
  • Micronit Microtechnologies B.V.
  • Kirkstall
  • Cherry Biotech SAS
  • Else Kooi Laboratory
  • Altis Biosystems
  • Bi/ond
  • Netri
  • Xona Microfluidics
  • SynVivo, Inc.
  • Beijing Daxiang Biotech
  • AVATARGET
  • Suzhou Jiyan Biopharmaceutical
  • InSphero

Segment by Type

  • Brain-on-a-chip
  • Liver-on-a-chip
  • Kidney-on-a-chip
  • Lung-on-a-chip
  • Heart-on-a-chip
  • Intestine-on-a-chip
  • Vessel-on-a-chip
  • Other Organs

Segment by End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Cosmetics Industry
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Organ On Chip company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Organ On Chip in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Organ On Chip in country level. It provides sigmate data by Type, and by End User for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Organ On Chip Product Introduction
  • 1.2 Global Organ On Chip Market Size Forecast (2020-2031)
  • 1.3 Organ On Chip Market Trends & Drivers
    • 1.3.1 Organ On Chip Industry Trends
    • 1.3.2 Organ On Chip Market Drivers & Opportunity
    • 1.3.3 Organ On Chip Market Challenges
    • 1.3.4 Organ On Chip Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Organ On Chip Players Revenue Ranking (2024)
  • 2.2 Global Organ On Chip Revenue by Company (2020-2025)
  • 2.3 Key Companies Organ On Chip Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Organ On Chip Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Organ On Chip
  • 2.6 Organ On Chip Market Competitive Analysis
    • 2.6.1 Organ On Chip Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Organ On Chip Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organ On Chip as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Brain-on-a-chip
    • 3.1.2 Liver-on-a-chip
    • 3.1.3 Kidney-on-a-chip
    • 3.1.4 Lung-on-a-chip
    • 3.1.5 Heart-on-a-chip
    • 3.1.6 Intestine-on-a-chip
    • 3.1.7 Vessel-on-a-chip
    • 3.1.8 Other Organs
  • 3.2 Global Organ On Chip Sales Value by Type
    • 3.2.1 Global Organ On Chip Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Organ On Chip Sales Value, by Type (2020-2031)
    • 3.2.3 Global Organ On Chip Sales Value, by Type (%) (2020-2031)

4 Segmentation by End User

  • 4.1 Introduction by End User
    • 4.1.1 Pharmaceutical & Biotechnology Companies
    • 4.1.2 Academic & Research Institutes
    • 4.1.3 Cosmetics Industry
    • 4.1.4 Others
  • 4.2 Global Organ On Chip Sales Value by End User
    • 4.2.1 Global Organ On Chip Sales Value by End User (2020 VS 2024 VS 2031)
    • 4.2.2 Global Organ On Chip Sales Value, by End User (2020-2031)
    • 4.2.3 Global Organ On Chip Sales Value, by End User (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Organ On Chip Sales Value by Region
    • 5.1.1 Global Organ On Chip Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Organ On Chip Sales Value by Region (2020-2025)
    • 5.1.3 Global Organ On Chip Sales Value by Region (2026-2031)
    • 5.1.4 Global Organ On Chip Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Organ On Chip Sales Value, 2020-2031
    • 5.2.2 North America Organ On Chip Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Organ On Chip Sales Value, 2020-2031
    • 5.3.2 Europe Organ On Chip Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Organ On Chip Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Organ On Chip Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Organ On Chip Sales Value, 2020-2031
    • 5.5.2 South America Organ On Chip Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Organ On Chip Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Organ On Chip Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Organ On Chip Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Organ On Chip Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Organ On Chip Sales Value, 2020-2031
    • 6.3.2 United States Organ On Chip Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Organ On Chip Sales Value by End User, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Organ On Chip Sales Value, 2020-2031
    • 6.4.2 Europe Organ On Chip Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Organ On Chip Sales Value by End User, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Organ On Chip Sales Value, 2020-2031
    • 6.5.2 China Organ On Chip Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Organ On Chip Sales Value by End User, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Organ On Chip Sales Value, 2020-2031
    • 6.6.2 Japan Organ On Chip Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Organ On Chip Sales Value by End User, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Organ On Chip Sales Value, 2020-2031
    • 6.7.2 South Korea Organ On Chip Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Organ On Chip Sales Value by End User, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Organ On Chip Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Organ On Chip Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Organ On Chip Sales Value by End User, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Organ On Chip Sales Value, 2020-2031
    • 6.9.2 India Organ On Chip Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Organ On Chip Sales Value by End User, 2024 VS 2031

7 Company Profiles

  • 7.1 Emulate
    • 7.1.1 Emulate Profile
    • 7.1.2 Emulate Main Business
    • 7.1.3 Emulate Organ On Chip Products, Services and Solutions
    • 7.1.4 Emulate Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Emulate Recent Developments
  • 7.2 Mimetas
    • 7.2.1 Mimetas Profile
    • 7.2.2 Mimetas Main Business
    • 7.2.3 Mimetas Organ On Chip Products, Services and Solutions
    • 7.2.4 Mimetas Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Mimetas Recent Developments
  • 7.3 TissUse
    • 7.3.1 TissUse Profile
    • 7.3.2 TissUse Main Business
    • 7.3.3 TissUse Organ On Chip Products, Services and Solutions
    • 7.3.4 TissUse Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.3.5 TissUse Recent Developments
  • 7.4 Valo Health
    • 7.4.1 Valo Health Profile
    • 7.4.2 Valo Health Main Business
    • 7.4.3 Valo Health Organ On Chip Products, Services and Solutions
    • 7.4.4 Valo Health Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Valo Health Recent Developments
  • 7.5 CN Bio Innovations
    • 7.5.1 CN Bio Innovations Profile
    • 7.5.2 CN Bio Innovations Main Business
    • 7.5.3 CN Bio Innovations Organ On Chip Products, Services and Solutions
    • 7.5.4 CN Bio Innovations Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.5.5 CN Bio Innovations Recent Developments
  • 7.6 Hesperos
    • 7.6.1 Hesperos Profile
    • 7.6.2 Hesperos Main Business
    • 7.6.3 Hesperos Organ On Chip Products, Services and Solutions
    • 7.6.4 Hesperos Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Hesperos Recent Developments
  • 7.7 Draper Laboratory
    • 7.7.1 Draper Laboratory Profile
    • 7.7.2 Draper Laboratory Main Business
    • 7.7.3 Draper Laboratory Organ On Chip Products, Services and Solutions
    • 7.7.4 Draper Laboratory Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Draper Laboratory Recent Developments
  • 7.8 Nortis
    • 7.8.1 Nortis Profile
    • 7.8.2 Nortis Main Business
    • 7.8.3 Nortis Organ On Chip Products, Services and Solutions
    • 7.8.4 Nortis Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Nortis Recent Developments
  • 7.9 Micronit Microtechnologies B.V.
    • 7.9.1 Micronit Microtechnologies B.V. Profile
    • 7.9.2 Micronit Microtechnologies B.V. Main Business
    • 7.9.3 Micronit Microtechnologies B.V. Organ On Chip Products, Services and Solutions
    • 7.9.4 Micronit Microtechnologies B.V. Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Micronit Microtechnologies B.V. Recent Developments
  • 7.10 Kirkstall
    • 7.10.1 Kirkstall Profile
    • 7.10.2 Kirkstall Main Business
    • 7.10.3 Kirkstall Organ On Chip Products, Services and Solutions
    • 7.10.4 Kirkstall Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Kirkstall Recent Developments
  • 7.11 Cherry Biotech SAS
    • 7.11.1 Cherry Biotech SAS Profile
    • 7.11.2 Cherry Biotech SAS Main Business
    • 7.11.3 Cherry Biotech SAS Organ On Chip Products, Services and Solutions
    • 7.11.4 Cherry Biotech SAS Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Cherry Biotech SAS Recent Developments
  • 7.12 Else Kooi Laboratory
    • 7.12.1 Else Kooi Laboratory Profile
    • 7.12.2 Else Kooi Laboratory Main Business
    • 7.12.3 Else Kooi Laboratory Organ On Chip Products, Services and Solutions
    • 7.12.4 Else Kooi Laboratory Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Else Kooi Laboratory Recent Developments
  • 7.13 Altis Biosystems
    • 7.13.1 Altis Biosystems Profile
    • 7.13.2 Altis Biosystems Main Business
    • 7.13.3 Altis Biosystems Organ On Chip Products, Services and Solutions
    • 7.13.4 Altis Biosystems Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Altis Biosystems Recent Developments
  • 7.14 Bi/ond
    • 7.14.1 Bi/ond Profile
    • 7.14.2 Bi/ond Main Business
    • 7.14.3 Bi/ond Organ On Chip Products, Services and Solutions
    • 7.14.4 Bi/ond Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Bi/ond Recent Developments
  • 7.15 Netri
    • 7.15.1 Netri Profile
    • 7.15.2 Netri Main Business
    • 7.15.3 Netri Organ On Chip Products, Services and Solutions
    • 7.15.4 Netri Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.15.5 Netri Recent Developments
  • 7.16 Xona Microfluidics
    • 7.16.1 Xona Microfluidics Profile
    • 7.16.2 Xona Microfluidics Main Business
    • 7.16.3 Xona Microfluidics Organ On Chip Products, Services and Solutions
    • 7.16.4 Xona Microfluidics Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.16.5 Xona Microfluidics Recent Developments
  • 7.17 SynVivo, Inc.
    • 7.17.1 SynVivo, Inc. Profile
    • 7.17.2 SynVivo, Inc. Main Business
    • 7.17.3 SynVivo, Inc. Organ On Chip Products, Services and Solutions
    • 7.17.4 SynVivo, Inc. Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.17.5 SynVivo, Inc. Recent Developments
  • 7.18 Beijing Daxiang Biotech
    • 7.18.1 Beijing Daxiang Biotech Profile
    • 7.18.2 Beijing Daxiang Biotech Main Business
    • 7.18.3 Beijing Daxiang Biotech Organ On Chip Products, Services and Solutions
    • 7.18.4 Beijing Daxiang Biotech Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.18.5 Beijing Daxiang Biotech Recent Developments
  • 7.19 AVATARGET
    • 7.19.1 AVATARGET Profile
    • 7.19.2 AVATARGET Main Business
    • 7.19.3 AVATARGET Organ On Chip Products, Services and Solutions
    • 7.19.4 AVATARGET Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.19.5 AVATARGET Recent Developments
  • 7.20 Suzhou Jiyan Biopharmaceutical
    • 7.20.1 Suzhou Jiyan Biopharmaceutical Profile
    • 7.20.2 Suzhou Jiyan Biopharmaceutical Main Business
    • 7.20.3 Suzhou Jiyan Biopharmaceutical Organ On Chip Products, Services and Solutions
    • 7.20.4 Suzhou Jiyan Biopharmaceutical Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.20.5 Suzhou Jiyan Biopharmaceutical Recent Developments
  • 7.21 InSphero
    • 7.21.1 InSphero Profile
    • 7.21.2 InSphero Main Business
    • 7.21.3 InSphero Organ On Chip Products, Services and Solutions
    • 7.21.4 InSphero Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.21.5 InSphero Recent Developments

8 Industry Chain Analysis

  • 8.1 Organ On Chip Industrial Chain
  • 8.2 Organ On Chip Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Organ On Chip Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Organ On Chip Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Organ On Chip Market Trends
  • Table 2. Organ On Chip Market Drivers & Opportunity
  • Table 3. Organ On Chip Market Challenges
  • Table 4. Organ On Chip Market Restraints
  • Table 5. Global Organ On Chip Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Organ On Chip Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Organ On Chip Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Organ On Chip Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Organ On Chip
  • Table 10. Global Organ On Chip Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organ On Chip as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Organ On Chip Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Organ On Chip Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Organ On Chip Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Organ On Chip Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Organ On Chip Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Organ On Chip Sales Value by End User: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Organ On Chip Sales Value by End User (2020-2025) & (US$ Million)
  • Table 20. Global Organ On Chip Sales Value by End User (2026-2031) & (US$ Million)
  • Table 21. Global Organ On Chip Sales Market Share in Value by End User (2020-2025)
  • Table 22. Global Organ On Chip Sales Market Share in Value by End User (2026-2031)
  • Table 23. Global Organ On Chip Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Organ On Chip Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Organ On Chip Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Organ On Chip Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Organ On Chip Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Organ On Chip Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Organ On Chip Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Organ On Chip Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Emulate Basic Information List
  • Table 32. Emulate Description and Business Overview
  • Table 33. Emulate Organ On Chip Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Organ On Chip Business of Emulate (2020-2025)
  • Table 35. Emulate Recent Developments
  • Table 36. Mimetas Basic Information List
  • Table 37. Mimetas Description and Business Overview
  • Table 38. Mimetas Organ On Chip Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Organ On Chip Business of Mimetas (2020-2025)
  • Table 40. Mimetas Recent Developments
  • Table 41. TissUse Basic Information List
  • Table 42. TissUse Description and Business Overview
  • Table 43. TissUse Organ On Chip Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Organ On Chip Business of TissUse (2020-2025)
  • Table 45. TissUse Recent Developments
  • Table 46. Valo Health Basic Information List
  • Table 47. Valo Health Description and Business Overview
  • Table 48. Valo Health Organ On Chip Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Organ On Chip Business of Valo Health (2020-2025)
  • Table 50. Valo Health Recent Developments
  • Table 51. CN Bio Innovations Basic Information List
  • Table 52. CN Bio Innovations Description and Business Overview
  • Table 53. CN Bio Innovations Organ On Chip Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Organ On Chip Business of CN Bio Innovations (2020-2025)
  • Table 55. CN Bio Innovations Recent Developments
  • Table 56. Hesperos Basic Information List
  • Table 57. Hesperos Description and Business Overview
  • Table 58. Hesperos Organ On Chip Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Organ On Chip Business of Hesperos (2020-2025)
  • Table 60. Hesperos Recent Developments
  • Table 61. Draper Laboratory Basic Information List
  • Table 62. Draper Laboratory Description and Business Overview
  • Table 63. Draper Laboratory Organ On Chip Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Organ On Chip Business of Draper Laboratory (2020-2025)
  • Table 65. Draper Laboratory Recent Developments
  • Table 66. Nortis Basic Information List
  • Table 67. Nortis Description and Business Overview
  • Table 68. Nortis Organ On Chip Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Organ On Chip Business of Nortis (2020-2025)
  • Table 70. Nortis Recent Developments
  • Table 71. Micronit Microtechnologies B.V. Basic Information List
  • Table 72. Micronit Microtechnologies B.V. Description and Business Overview
  • Table 73. Micronit Microtechnologies B.V. Organ On Chip Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Organ On Chip Business of Micronit Microtechnologies B.V. (2020-2025)
  • Table 75. Micronit Microtechnologies B.V. Recent Developments
  • Table 76. Kirkstall Basic Information List
  • Table 77. Kirkstall Description and Business Overview
  • Table 78. Kirkstall Organ On Chip Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Organ On Chip Business of Kirkstall (2020-2025)
  • Table 80. Kirkstall Recent Developments
  • Table 81. Cherry Biotech SAS Basic Information List
  • Table 82. Cherry Biotech SAS Description and Business Overview
  • Table 83. Cherry Biotech SAS Organ On Chip Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Organ On Chip Business of Cherry Biotech SAS (2020-2025)
  • Table 85. Cherry Biotech SAS Recent Developments
  • Table 86. Else Kooi Laboratory Basic Information List
  • Table 87. Else Kooi Laboratory Description and Business Overview
  • Table 88. Else Kooi Laboratory Organ On Chip Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Organ On Chip Business of Else Kooi Laboratory (2020-2025)
  • Table 90. Else Kooi Laboratory Recent Developments
  • Table 91. Altis Biosystems Basic Information List
  • Table 92. Altis Biosystems Description and Business Overview
  • Table 93. Altis Biosystems Organ On Chip Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Organ On Chip Business of Altis Biosystems (2020-2025)
  • Table 95. Altis Biosystems Recent Developments
  • Table 96. Bi/ond Basic Information List
  • Table 97. Bi/ond Description and Business Overview
  • Table 98. Bi/ond Organ On Chip Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Organ On Chip Business of Bi/ond (2020-2025)
  • Table 100. Bi/ond Recent Developments
  • Table 101. Netri Basic Information List
  • Table 102. Netri Description and Business Overview
  • Table 103. Netri Organ On Chip Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in Organ On Chip Business of Netri (2020-2025)
  • Table 105. Netri Recent Developments
  • Table 106. Xona Microfluidics Basic Information List
  • Table 107. Xona Microfluidics Description and Business Overview
  • Table 108. Xona Microfluidics Organ On Chip Products, Services and Solutions
  • Table 109. Revenue (US$ Million) in Organ On Chip Business of Xona Microfluidics (2020-2025)
  • Table 110. Xona Microfluidics Recent Developments
  • Table 111. SynVivo, Inc. Basic Information List
  • Table 112. SynVivo, Inc. Description and Business Overview
  • Table 113. SynVivo, Inc. Organ On Chip Products, Services and Solutions
  • Table 114. Revenue (US$ Million) in Organ On Chip Business of SynVivo, Inc. (2020-2025)
  • Table 115. SynVivo, Inc. Recent Developments
  • Table 116. Beijing Daxiang Biotech Basic Information List
  • Table 117. Beijing Daxiang Biotech Description and Business Overview
  • Table 118. Beijing Daxiang Biotech Organ On Chip Products, Services and Solutions
  • Table 119. Revenue (US$ Million) in Organ On Chip Business of Beijing Daxiang Biotech (2020-2025)
  • Table 120. Beijing Daxiang Biotech Recent Developments
  • Table 121. AVATARGET Basic Information List
  • Table 122. AVATARGET Description and Business Overview
  • Table 123. AVATARGET Organ On Chip Products, Services and Solutions
  • Table 124. Revenue (US$ Million) in Organ On Chip Business of AVATARGET (2020-2025)
  • Table 125. AVATARGET Recent Developments
  • Table 126. Suzhou Jiyan Biopharmaceutical Basic Information List
  • Table 127. Suzhou Jiyan Biopharmaceutical Description and Business Overview
  • Table 128. Suzhou Jiyan Biopharmaceutical Organ On Chip Products, Services and Solutions
  • Table 129. Revenue (US$ Million) in Organ On Chip Business of Suzhou Jiyan Biopharmaceutical (2020-2025)
  • Table 130. Suzhou Jiyan Biopharmaceutical Recent Developments
  • Table 131. InSphero Basic Information List
  • Table 132. InSphero Description and Business Overview
  • Table 133. InSphero Organ On Chip Products, Services and Solutions
  • Table 134. Revenue (US$ Million) in Organ On Chip Business of InSphero (2020-2025)
  • Table 135. InSphero Recent Developments
  • Table 136. Key Raw Materials Lists
  • Table 137. Raw Materials Key Suppliers Lists
  • Table 138. Organ On Chip Downstream Customers
  • Table 139. Organ On Chip Distributors List
  • Table 140. Research Programs/Design for This Report
  • Table 141. Key Data Information from Secondary Sources
  • Table 142. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Organ On Chip Product Picture
  • Figure 2. Global Organ On Chip Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Organ On Chip Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Organ On Chip Report Years Considered
  • Figure 5. Global Organ On Chip Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Organ On Chip Revenue in 2024
  • Figure 7. Organ On Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Brain-on-a-chip Picture
  • Figure 9. Liver-on-a-chip Picture
  • Figure 10. Kidney-on-a-chip Picture
  • Figure 11. Lung-on-a-chip Picture
  • Figure 12. Heart-on-a-chip Picture
  • Figure 13. Intestine-on-a-chip Picture
  • Figure 14. Vessel-on-a-chip Picture
  • Figure 15. Other Organs Picture
  • Figure 16. Global Organ On Chip Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 17. Global Organ On Chip Sales Value Market Share by Type, 2024 & 2031
  • Figure 18. Product Picture of Pharmaceutical & Biotechnology Companies
  • Figure 19. Product Picture of Academic & Research Institutes
  • Figure 20. Product Picture of Cosmetics Industry
  • Figure 21. Product Picture of Others
  • Figure 22. Global Organ On Chip Sales Value by End User (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 23. Global Organ On Chip Sales Value Market Share by End User, 2024 & 2031
  • Figure 24. North America Organ On Chip Sales Value (2020-2031) & (US$ Million)
  • Figure 25. North America Organ On Chip Sales Value by Country (%), 2024 VS 2031
  • Figure 26. Europe Organ On Chip Sales Value, (2020-2031) & (US$ Million)
  • Figure 27. Europe Organ On Chip Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Asia Pacific Organ On Chip Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Asia Pacific Organ On Chip Sales Value by Region (%), 2024 VS 2031
  • Figure 30. South America Organ On Chip Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. South America Organ On Chip Sales Value by Country (%), 2024 VS 2031
  • Figure 32. Middle East & Africa Organ On Chip Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. Middle East & Africa Organ On Chip Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Key Countries/Regions Organ On Chip Sales Value (%), (2020-2031)
  • Figure 35. United States Organ On Chip Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. United States Organ On Chip Sales Value by Type (%), 2024 VS 2031
  • Figure 37. United States Organ On Chip Sales Value by End User (%), 2024 VS 2031
  • Figure 38. Europe Organ On Chip Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. Europe Organ On Chip Sales Value by Type (%), 2024 VS 2031
  • Figure 40. Europe Organ On Chip Sales Value by End User (%), 2024 VS 2031
  • Figure 41. China Organ On Chip Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. China Organ On Chip Sales Value by Type (%), 2024 VS 2031
  • Figure 43. China Organ On Chip Sales Value by End User (%), 2024 VS 2031
  • Figure 44. Japan Organ On Chip Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. Japan Organ On Chip Sales Value by Type (%), 2024 VS 2031
  • Figure 46. Japan Organ On Chip Sales Value by End User (%), 2024 VS 2031
  • Figure 47. South Korea Organ On Chip Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. South Korea Organ On Chip Sales Value by Type (%), 2024 VS 2031
  • Figure 49. South Korea Organ On Chip Sales Value by End User (%), 2024 VS 2031
  • Figure 50. Southeast Asia Organ On Chip Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. Southeast Asia Organ On Chip Sales Value by Type (%), 2024 VS 2031
  • Figure 52. Southeast Asia Organ On Chip Sales Value by End User (%), 2024 VS 2031
  • Figure 53. India Organ On Chip Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. India Organ On Chip Sales Value by Type (%), 2024 VS 2031
  • Figure 55. India Organ On Chip Sales Value by End User (%), 2024 VS 2031
  • Figure 56. Organ On Chip Industrial Chain
  • Figure 57. Organ On Chip Manufacturing Cost Structure
  • Figure 58. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 59. Bottom-up and Top-down Approaches for This Report
  • Figure 60. Data Triangulation
  • Figure 61. Key Executives Interviewed